[Usefulness and safety of segmental-subsegmental TAE for hepatocellular carcinoma in cases of liver hypofunction].
We analyzed the safety of the segmental-subsegmental TAE for hepatocellular carcinoma in 18 cases of liver hypofunction by checking total bilirubin change after TAE. The TAE was performed safely in all of the cases. The highest value of total bilirubin before TAE was 5.1 mg/dl in the 1-2 subsegment TAE group, 3.8 mg/dl in the 3-4 subsegment TAE group and 2.0 mg/dl in the 6 subsegment TAE group. We conclude that segmental TAE is safe even in the patient of liver hypofunction.